Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 studyChristian Buske, Michinori Ogura, Jin Seok Kim et al.|Blood Advances|2021Cited by 9
Similar Efficacy and Safety of CT-P10 and Reference Rituximab in Patients with Advanced Stage Follicular Lymphoma: Updated Phase III Study ResultsWon-Seog Kim, SuYoung Kim, Christian Buske et al.|Blood|2018Cited by 4